Latest Anti-diabetic medication Stories
Another Actos Lawsuit Purports Patient Develop Bladder Cancer After Taking The Type Two Diabetes Medication Columbus, OH (PRWEB) October 18, 2014 Wright
Prescribers Are Enthusiastic about the SGLT-2 Inhibitors, but Payers Are Not Fully Convinced of the Added Benefits of These Agents, According to Findings from Decision Resources Group BURLINGTON,
The Firm is evaluating Byetta lawsuits and other legal claims that allege the use of diabetes drugs called incretin mimetics caused patients to develop pancreatic cancer, pancreatitis or thyroid
Pegasus Legal Funding LLC Can Provide Financial Assistance to Those Adversely Affected NEW YORK, Oct.
The Actos Lawsuit Purports Takeda Pharmceuticals Knew Long-Term Use Of The Medication Could Potentially Lead To Bladder Cancer. Columbus, OH (PRWEB) October
Expresses Continued Confidence in ACTOS DEERFIELD, Ill., Oct. 3, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc.
-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications.
Diabetes Miracle Cure reviews have been flooding the Internet and HealthyandFitZone.com reveals the truth about this method to cure diabetes permanently, without the need of using any outdated
Culinary Expert Visits San Diego County on September 20 to Help Educate At-Risk Population About Ingredients for Successful Blood Sugar Management WHITEHOUSE STATION, N.J.,
- Trulicity, a weekly glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for adults with type 2 diabetes as an adjunct to diet and exercise INDIANAPOLIS, Sept.